Weekly GLP-1 News Roundup (Oct 23, 2026): A Pill Nears Europe, CagriSema Data, and New Pregnancy Guidance
This week: Lilly’s Foundayo pill moved closer to EU approval, Novo shared new CagriSema data for women, a compounded tirzepatide product was recalled, and ACOG released GLP-1 pregnancy guidance.